Angelman Syndrome Treatment Market would rocket up to USD 220.64 million by 2030

The incidence of angelman syndromes can vary among different populations and age groups. However, the increase in government initiatives in developing treatment options for angelman syndrome drives the global angelman syndrome treatment market. Moreover, increased health and R&D expenditure also boosts the market growth.

Data Bridge Market Research analyses that the angelman syndrome treatment market which was USD 143.77 million in 2022, would rocket up to USD 220.64 million by 2030, and is expected to undergo a CAGR of 5.5% during the forecast period. This indicates the market value. "physical therapy" dominates the treatment segment of the angelman syndrome treatment market owing to the growing demand for better surgical methods for treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read More:
https://www.databridgemarketresearch.com/reports/global-angelman-syndrome-treatment-market

Market Definition

Angelman syndrome is a very rare genetic disorder that affects the nervous system. This syndrome is caused by a loss of function in the UBE3A gene on the maternal 15th chromosome. People suffering from angelman disorder have excitable personalities and they frequently laugh and smile. Major symptoms of angelman syndrome are lack of speech, balance issues and seizures. Sometimes tongue thrusting, Jerky movement may occur.

Global Angelman Syndrome Treatments Market Dynamics
Drivers

Rising prevalence of speech disorders
The rising prevalence of speech disorders such as stuttering, apraxia, and others among children and adults is expected to fuel the global angelman syndrome treatments market. Furthermore, the rising prevalence of chronic illnesses such as brain injuries, tumours, Parkinson's disease, autism, cerebral palsy and stroke is also expected to drive the global angelman syndrome treatments market. Expressive disorders, voice disorders, articulation disorders, fluency disorders, and language disorders such as receptive disorders and cognitive-communication disorders are all instances of speech disorders. The emergence of these disorders is boosting the global angelman syndrome treatments market.

Increasing investment in healthcare infrastructure
Another significant factor influencing the growth rate of angelman syndrome treatments market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Opportunities

Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the angelman syndrome treatments and will further create lucrative market growth opportunities. Research and development proficiencies being conducted to provide best of the medications to curb the Angelman Syndrome is also bolstering the market growth rate.

Increase in the number of research and development activities
The increase in the number of research and development activities is estimated to provide various beneficial opportunities for the neurological disorder drugs market's growth. New therapeutic techniques for the treatment of angelman syndrome are being adopted by companies in the neurological disorder pharmaceuticals market. This leads to high number of research activities to better understand the disease's genetic risk factors in order to find better drugs.

GET PDF SAMPLE:

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-angelman-syndrome-treatment-market

Some of the major players operating in the angelman syndrome treatment market are:

Smart Speech Therapy (U.S.)

SPEECH THERAPY SOLUTIONS, INC. (U.S.)

Talk Speech and Language Therapy Ltd. (U.K.)

Glenda Browne Speech Pathology (Australia)

Benchmark Therapies, Inc (U.S.)

speech plus (U.S.)

Integrated Treatment Services (U.S.)

Speechworks Therapy Services (U.S.)

Acapela Group (Belgium)

Advanced Voice Recognition Systems, Inc. (U.S.)

Open Text Corporation (Canada)

Cleveland Clinic (U.S.)

Therapy Solutions Inc (U.S.)

Merck KGaA (Germany)

Eisai Co., Ltd. (Japan)

AstraZeneca (U.K.)

Sanofi (France)

Novartis AG (Switzerland)

Abbott (U.S.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Teva Pharmaceutical Industries Ltd. (Ireland)

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (U.K.)

GET MORE LINKS:

https://dbmrbuisness.blogspot.com/2023/08/global-implantable-loop-recorders.html

https://dbmrbuisness.blogspot.com/2023/08/global-thymic-cancer-treatment-market.html

https://dbmrbuisness.blogspot.com/2023/08/global-brain-tumor-diagnosis-and.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.